RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033

Publish Date: May 2024

Report Code: TBR3711A

Publisher: TBRC (Publisher)

Download Report Overview

Single User License: $5000

Explore Our Services

Already a member? Login here.

Sample Report

Report Highlights

Including: 1) By Product: Antisense Oligonucleotides (ASOS); Small Interfering RNA (SIRNA)
2) By Therapeutic Indication: Musculoskeletal Disorder; Neurodegenerative Diseases; Cardiovascular Disease; Genito-Urinary; Therapeutic Indications
3) By End User: Hospitals; Research Laboratories; Pharmaceutical And Biotechnology Companies
Covering: Ionis Pharmaceuticals; Alnylam Pharmaceuticals; Sarepta Therapeutics; Jazz Pharmaceuticals; Novartis

RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global RNA targeting small molecules therapeutics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:
Where is the largest and fastest-growing market for RNA targeting small molecules therapeutics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The RNA targeting small molecules therapeutics market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider RNA targeting small molecules therapeutics market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by therapeutic indication and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the RNA targeting small molecules therapeutics market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by therapeutic indication and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for RNA targeting small molecules therapeutics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Report Synopsis

Report Metrics	Details
Base year considered	2023
Forecast period considered	2023-2033
Units considered	$ Million
Segments covered	By Product, By Therapeutic Indication, By End User
Industry covered	Pharmaceuticals
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	China, Australia, India, Indonesia, Japan, South Korea, USA, Canada, Brazil, France, Germany, Italy, Spain, UK, Russia
Companies studied	Ionis Pharmaceuticals Jazz Pharmaceuticals Alnylam Pharmaceuticals Sarepta Therapeutics Novartis

Scope

Markets Covered:

By Product: Antisense Oligonucleotides (ASOs); Small Interfering RNA (siRNA)
By Therapeutic Indication: Musculoskeletal Disorder; Neurodegenerative Diseases; Cardiovascular Disease; Genito-Urinary; Therapeutic Indications
By End User: Hospitals; Research Laboratories; Pharmaceutical and Biotechnology Companies; Other End-Users

Companies Mentioned: Ionis Pharmaceuticals; Alnylam Pharmaceuticals; Sarepta Therapeutics; Jazz Pharmaceuticals; Novartis

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; RNA targeting small molecules therapeutics indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table 1 : Global RNA Targeting Small Molecules Therapeutics Market, Historic, 2018 – 2023, $ Million
Table 2 : Global RNA Targeting Small Molecules Therapeutics Market, Forecast, 2023 – 2028, 2033F, $ Million
Table 3 : Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 4 : Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 5 : Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 6 : Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 7 : Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 8 : Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
Table 9 : Asia-Pacific Population, By Country, 2018-2028, Millions
Table 10 : Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 11 : Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 12 : Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 13 : China GDP Per Capita, 2018-2023, $
Table 14 : China Population, 2018-2028, Millions
Table 15 : China RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 16 : China RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 17 : China RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 18 : India RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 19 : India RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 20 : India RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 21 : Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 22 : Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 23 : Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 24 : Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 25 : Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 26 : Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 27 : Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 28 : Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 29 : Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 30 : South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 31 : South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 32 : South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 33 : Western Europe GDP Per Capita, By Country, 2018-2023, $
Table 34 : Western Europe Population, By Country, 2018-2028, Millions
Table 35 : Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 36 : Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 37 : Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 38 : UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 39 : UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 40 : UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 41 : Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 42 : Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 43 : Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 44 : France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 45 : France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 46 : France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 47 : Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 48 : Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 49 : Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 50 : Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 51 : Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 52 : Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 53 : Eastern Europe GDP Per Capita, By Country, 2018-2023, $
Table 54 : Eastern Europe Population, By Country, 2018-2028, Millions
Table 55 : Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 56 : Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 57 : Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 58 : Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 59 : Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 60 : Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 61 : North America GDP Per Capita, By Country, 2018-2023, $
Table 62 : North America Population, By Country, 2018-2028, Millions
Table 63 : North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 64 : North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 65 : North America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 66 : USA GDP Per Capita, 2018-2023, $
Table 67 : USA Population, 2018-2028, Millions
Table 68 : USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 69 : USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 70 : USA RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 71 : Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 72 : Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 73 : Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 74 : South America GDP Per Capita, By Country, 2018-2023, $
Table 75 : South America Population, By Country, 2018-2028, Millions
Table 76 : South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 77 : South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 78 : South America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 79 : Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 80 : Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 81 : Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 82 : Middle East GDP Per Capita, By Country, 2018-2023, $
Table 83 : Middle East Population, By Country, 2018-2028, Millions
Table 84 : Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 85 : Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 86 : Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 87 : Africa GDP Per Capita, By Country, 2018-2023, $
Table 88 : Africa Population, By Country, 2018-2028, Millions
Table 89 : Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 90 : Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 91 : Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Table 92 : Global RNA Targeting Small Molecules Therapeutics Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
Table 93 : Ionis Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion
Table 94 : Alnylam Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion
Table 95 : Sarepta Therapeutics – Financial Overview, 2018 – 2022, $ Billion
Table 96 : Jazz Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion
Table 97 : Novartis – Financial Overview, 2018 – 2022, $ Billion
Table 98 : RNA Targeting Small Molecules Therapeutics Market, Competitive Benchmarking (In USD Millions)
Table 99 : RNA Targeting Small Molecules Therapeutics Market, Competitive Dashboard
Table 100 : Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), 2023 – 2028, By Country
Table 101 : Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), Segmentation By Type, 2023 – 2028
Table 102 : Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), Segmentation By Therapeutic Indication, 2023 – 2028
Table 103 : Global RNA Targeting Small Molecules Therapeutics Market Size Gain ($ Million), Segmentation By End-User, 2023 – 2028
Table 104 : RNA Targeting Small Molecules Therapeutics Market Data Sources

Figure 1 : Global RNA Targeting Small Molecules Therapeutics Market Segmentation By Product
Figure 2 : Global RNA Targeting Small Molecules Therapeutics Market Segmentation By Therapeutic Indication
Figure 3 : Global RNA Targeting Small Molecules Therapeutics Market Segmentation By End-User
Figure 4 : Global RNA Targeting Small Molecules Therapeutics Market, Historic, 2018 – 2023, $ Million
Figure 5 : Global RNA Targeting Small Molecules Therapeutics Market, Forecast, 2023 – 2028, 2033F, $ Million
Figure 6 : Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 7 : Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 8 : Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 9 : Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 10 : Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 11 : Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 12 : Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 13 : Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 14 : China RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 15 : China RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 16 : China RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 17 : India RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 18 : India RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 19 : India RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 20 : Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 21 : Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 22 : Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 23 : Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 24 : Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 25 : Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 26 : Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 27 : Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 28 : Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 29 : South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 30 : South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 31 : South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 32 : Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 33 : Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 34 : Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 35 : UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 36 : UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 37 : UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 38 : Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 39 : Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 40 : Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 41 : France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 42 : France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 43 : France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 44 : Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 45 : Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 46 : Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 47 : Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 48 : Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 49 : Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 50 : Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 51 : Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 52 : Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 53 : Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 54 : Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 55 : Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 56 : North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 57 : North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 58 : North America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 59 : USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 60 : USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 61 : USA RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 62 : Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 63 : Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 64 : Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 65 : South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 66 : South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 67 : South America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 68 : Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 69 : Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 70 : Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 71 : Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 72 : Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 73 : Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 74 : Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 75 : Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 76 : Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
Figure 77 : Global RNA Targeting Small Molecules Therapeutics Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
Figure 78 : Ionis Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion
Figure 79 : Alnylam Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion
Figure 80 : Sarepta Therapeutics – Financial Overview, 2018 – 2022, $ Billion
Figure 81 : Jazz Pharmaceuticals – Financial Overview, 2018 – 2022, $ Billion
Figure 82 : Novartis – Financial Overview, 2018 – 2022, $ Billion
Figure 83 : Geographic Regions Covered

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

FAQ

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More

RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033

Report Highlights

Report Synopsis

Recent Reports

Top Trending Reports

Become A Member

Custom Consulting

Scorecard

Innovation Spotlight